Cell biologist interested in melanoma research. Group Leader @ Instituto de Investigaciones Biomedicas Alberto Sols CSIC-UAM @IIBmCSICUAM. @jlorgaz.bsky.social
Interested in the cytoskeleton and therapy resistance, in particular in melanoma? Have a look at our review just published
https://t.co/74fgVPk0ui
@IIBmCSICUAM
Thanks so much @CicMechano for the invitation!
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
Delighted to share our latest piece on our favourite cancer cells! Well done @RitobrataGhose 👏
Amoeboid cancer cells at a glance https://t.co/QX0golMCW7
Representing the Cytoskeleton and Metastasis Lab @IIBmCSICUAM at the 19th International #ASEICACongress with our great group leader @JoseOrgaz2 & my amazing lab mate Marta Durán. We’re really enjoying being able to share results & learning from great scientists @ASEICAnews
Excited to co-organize the virtual @EACRnews@Boehringer Conference: Drugging & Regulating the MAP Kinase Pathway! Submit an abstract or join us. Please RT and share with others.
Details & registration:
https://t.co/KmKFU3xpcz
-80º C freezer - recommendations?
Bought a Stirling ultracold two years ago, absolute nightmare - door changed, handle changed, circuit board changed, 4 service requests in just two years.
Would very much appreciate any recommendations for a -80 freezer.
Paper @Dev_Cell@MegDrisc @DanuserLab
Proteolysis-free amoeboid migration of melanoma cells through crowded environments via bleb-driven worrying
https://t.co/DsPtG4kU6B
Delighted to comment on a beautiful paper by @MegDrisc @DanuserLab
Creating a path during melanoma amoeboid migration: When too crowded, start worrying https://t.co/uqcufSc21l
@IIBmCSICUAM
Excited to share our new
@biorxivpreprint in which we demonstrate the formation and maintenance of cellular memories in melanoma during acquisition of therapy resistance - dependent on the transcription factor AP-1 https://t.co/YBa6Gtbq5i (1/9)
Very cool and important work from @MariaDMayan lab showing that Connexin43 enhances response to MAPKi in melanoma and other cancers. congrats @adrianvarelavaz@MariaDMayan and the rest of the team!